138 related articles for article (PubMed ID: 12970299)
1. Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma.
Boltze C; Mundschenk J; Unger N; Schneider-Stock R; Peters B; Mawrin C; Hoang-Vu C; Roessner A; Lehnert H
J Clin Endocrinol Metab; 2003 Sep; 88(9):4280-6. PubMed ID: 12970299
[TBL] [Abstract][Full Text] [Related]
2. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.
Boltze C; Lehnert H; Schneider-Stock R; Peters B; Hoang-Vu C; Roessner A
Endocrine; 2003 Dec; 22(3):193-201. PubMed ID: 14709792
[TBL] [Abstract][Full Text] [Related]
3. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
4. Function of HSP90 and p23 in the telomerase complex of thyroid tumors.
Boltze C; Schneider-Stock R; Roessner A; Quednow C; Hoang-Vu C
Pathol Res Pract; 2003; 199(9):573-9. PubMed ID: 14621192
[TBL] [Abstract][Full Text] [Related]
5. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of telomerase activity in malignant pheochromocytoma.
Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of human telomerase catalytic subunit mRNA by in situ hybridization in pheochromocytomas.
Luo Z; Li J; Qin Y; Ma Y; Liang X; Xian J; Lu D; Wei M; Yang JY; Yang MQ; He Z
Endocr Pathol; 2006; 17(4):387-98. PubMed ID: 17525487
[TBL] [Abstract][Full Text] [Related]
8. Microarray analysis reveals differential expression of benign and malignant pheochromocytoma.
Waldmann J; Fendrich V; Holler J; Buchholz M; Heinmöller E; Langer P; Ramaswamy A; Samans B; Walz MK; Rothmund M; Bartsch DK; Slater EP
Endocr Relat Cancer; 2010 Sep; 17(3):743-56. PubMed ID: 20562231
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy.
Thouënnon E; Elkahloun AG; Guillemot J; Gimenez-Roqueplo AP; Bertherat J; Pierre A; Ghzili H; Grumolato L; Muresan M; Klein M; Lefebvre H; Ouafik L; Vaudry H; Plouin PF; Yon L; Anouar Y
J Clin Endocrinol Metab; 2007 Dec; 92(12):4865-72. PubMed ID: 17878247
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
[TBL] [Abstract][Full Text] [Related]
11. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis regulating genes, bcl-2 and bax, and human telomerase reverse transcriptase messenger RNA expression in adrenal tumors: possible diagnostic and prognostic importance.
Kanauchi H; Wada N; Clark OH; Duh QY
Surgery; 2002 Dec; 132(6):1021-6; discussion 1026-7. PubMed ID: 12490850
[TBL] [Abstract][Full Text] [Related]
13. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
Yano Y; Yoshida K; Osaki A; Toge T; Tahara H; Ide T; Yasui W
Anticancer Res; 2002; 22(6C):4101-7. PubMed ID: 12553039
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
[TBL] [Abstract][Full Text] [Related]
15. Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuroblastoma tissues.
Isobe K; Yashiro T; Omura S; Kaneko M; Kaneko S; Kamma H; Tatsuno I; Takekoshi K; Kawakami Y; Nakai T
Endocr J; 2004 Feb; 51(1):47-52. PubMed ID: 15004408
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of telomerase activity by six telomerase subunits.
Chang JT; Chen YL; Yang HT; Chen CY; Cheng AJ
Eur J Biochem; 2002 Jul; 269(14):3442-50. PubMed ID: 12135483
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity and hTERT mRNA expression in body fluids.
Yamamoto Y; Hirakawa E
Diagn Cytopathol; 2005 Mar; 32(3):167-70. PubMed ID: 15690332
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
